» Articles » PMID: 21069583

Tissue-regenerating, Vision-restoring Corneal Epithelial Stem Cells

Overview
Publisher Springer
Specialty Cell Biology
Date 2010 Nov 12
PMID 21069583
Citations 17
Authors
Affiliations
Soon will be listed here.
Abstract

The cornea, the most anterior segment of the eye, provides us with exquisite vision. Unlike other vital tissues, it is poorly protected from the environment and is thus reliant on a self-renewal program to preserve integrity. This function is reserved for corneal epithelial stem cells located in the basal layer of the limbus, a narrow transition zone that segregates the peripheral cornea from the adjacent conjunctiva. Under physiological conditions, these cells replenish the corneal epithelium when mature or traumatized cells are lost. However, when the limbus is extensively damaged, stem cell activity is compromised, resulting in a condition known as limbal stem cell deficiency (LSCD). This disease is characterized by corneal neovascularization and persistent epithelial defects which impair vision. Over the past 20 years a myriad of treatment options have been developed for LSCD, most of which incorporate stem cell transplantation. Due to the disadvantages associated with the use of allogeneic and xenogeneic material, researchers are currently focusing on refining techniques involving autologous limbal tissue transplantation and are delving into the possibility that stem cells found in other organs can provide an alternative source of corneal epithelium. Determining where donor stem cells reside on the recipient's ocular surface and how long they remain viable will provide further insights into improving current therapeutic options for patients with LSCD.

Citing Articles

Stem Cell Niche Microenvironment: Review.

Abdul-Al M, Kyeremeh G, Saeinasab M, Heidari Keshel S, Sefat F Bioengineering (Basel). 2021; 8(8).

PMID: 34436111 PMC: 8389324. DOI: 10.3390/bioengineering8080108.


Ex Vivo Corneal Organ Culture Model for Wound Healing Studies.

Castro N, Gillespie S, Bernstein A J Vis Exp. 2019; (144).

PMID: 30829330 PMC: 7641194. DOI: 10.3791/58562.


Induced pluripotent stem cells as a potential therapeutic source for corneal epithelial stem cells.

Zhu J, Slevin M, Guo B, Zhu S Int J Ophthalmol. 2018; 11(12):2004-2010.

PMID: 30588437 PMC: 6288540. DOI: 10.18240/ijo.2018.12.21.


Bmi1+ Progenitor Cell Dynamics in Murine Cornea During Homeostasis and Wound Healing.

Kalha S, Shrestha B, Sanz Navarro M, Jones K, Klein O, Michon F Stem Cells. 2017; 36(4):562-573.

PMID: 29282831 PMC: 5929111. DOI: 10.1002/stem.2767.


Using optical coherence tomography to assess the role of age and region in corneal epithelium and palisades of vogt.

Lin H, Tew T, Hsieh Y, Lin S, Chang H, Hu F Medicine (Baltimore). 2016; 95(35):e4234.

PMID: 27583846 PMC: 5008530. DOI: 10.1097/MD.0000000000004234.


References
1.
Ahmad S, Kolli S, Lako M, Figueiredo F, Daniels J . Stem cell therapies for ocular surface disease. Drug Discov Today. 2010; 15(7-8):306-13. DOI: 10.1016/j.drudis.2010.02.001. View

2.
Boneva R, Folks T, Chapman L . Infectious disease issues in xenotransplantation. Clin Microbiol Rev. 2001; 14(1):1-14. PMC: 88959. DOI: 10.1128/CMR.14.1.1-14.2001. View

3.
Schwab I . Cultured corneal epithelia for ocular surface disease. Trans Am Ophthalmol Soc. 2000; 97:891-986. PMC: 1298283. View

4.
Tsai R, Li L, Chen J . Reconstruction of damaged corneas by transplantation of autologous limbal epithelial cells. N Engl J Med. 2000; 343(2):86-93. DOI: 10.1056/NEJM200007133430202. View

5.
Chee K, Kicic A, Wiffen S . Limbal stem cells: the search for a marker. Clin Exp Ophthalmol. 2006; 34(1):64-73. DOI: 10.1111/j.1442-9071.2006.01147.x. View